Abstract
The high potential of peptides and proteins as therapeutic agents has not been fully exploited because of their common shortcomings: the only exist for a short lifetime in the body, they degrade easily in vivo and in vitro, and they cause immunological reactions. Among several proposed solutions, PEGylation, the covalent modification using polyethylene-glycol (PEG), has achieved interesting results, leading to a novel series of products that have already reached the market, while others will be available soon. In the past few years this technology, first developed for peptides and proteins, has been applied to non-peptide drugs, opening a new area of investigation that is receiving increasing interest. In this case, PEGylation allows the therapeutic application of molecules with inadequate water solubility, high toxicity, or a poor pharmacokinetic profile. This chapter describes recent achievements in PEGylation of proteins and peptides, with a special emphasis on the chemistry of conjugation, and it reports many examples from literature and from the authors' own experimental results.
Preview
Unable to display preview. Download preview PDF.
References
Davis FF, Abuchowski A, Van Es T, Palczuk NC, Chen R, Savoca K, Wieder K (1978) Enzyme Eng 4:169
Duncan R (2003) Nat Rev Drug Discov 2:347
Kopećek J, Kopeckova P, Minko T, Lu Z (2000) Eur Pharm J Biopharm 50:61
Harris JM, Chess RB (2003) Nat Rev Drug Discov 2:214
Veronese FM, Morpurgo M (1999) Farmaco 54:497
Harris JM, Martin NE, Modi M (2001) Clin Pharmacokinet 40:539
Davis FF, Kazo GM, Nucci ML, Abuchowski A (1990) In: Lee VHL (ed) Peptide and protein drug delivery. Dekker, New York, p 226
Nucci ML, Schorr R, Abuchowski A (1991) Adv Drug Deliv Rev 6:133
Russell-Jones GJ (1996) Adv Drug Deliv Rev 20:83
Okamoto CT (1998) Adv Drug Deliv Rev 29:215
Takakura Y, Mahoto Ri, Hashida M (1998) Adv Drug Deliv Rev 34:93
Allen TM (2002) Nat Rev Cancer 2:750
Bailon P, Berthold W (1998) Pharm Sci Technol Today 1:352
Zaplisky S, Harris JM (1997) In: Chemistry and biological applications of polyethylene glycol. American Chemical Society, San Francisco
Veronese FM (2001) Biomaterials 22:405
Levy Y, Hershfield MS, Fernandez-Mejia C et al. (1988) J Pediatr 113:312
Graham LM (2003) Adv Drug Deliv Rev 10:1293
Wang YS, Youngster S, Grace M, Bausch J, Bordens R, Wyss DF (2002) Adv Drug Deliv Rev 54:547
Bailon P, Palleroni A, Schaffer CA et al. (2001) Bioconjugate Chem 12:195
Reddy KR, Modi MW, Pedder S (2002) Adv Drug Deliv Rev 54:571
Trainer PJ, Drake WM, Katznelson L et al. (2000) N Engl J Med 342:1171
Kinstler O, Moulinex G, Treheit M et al. (2002) Adv Drug Deliv Rev 54:477
Eyetech Study Group (2002) Retina 22:143
Abuchowski A, Van Es T, Palczuk NC, Davis FF (1977) J Biol Chem 252:3578
Manjula BN, Tsai A, Upadhya R et al. (2003) Bioconj Chem 14:464
Working PK, Newman SS, Johnson J, Cornacoff JB (1997) Safety of poly(ethylene glycol) derivatives. In: Harris JM, Zalipsky S (eds) Poly(ethylene glycol) chemistry and biological applications. ACS, Washington, p 45
Petrak K, Goddard P (1989) Adv Drug Deliv Rev 3:191
Friman S, Egestad B, Sjovatt J, Svanvik J (1993) J Hepatol 17:48
Guiotto A, Canevari M, Pozzobon M, Moro S, Orsolini P, Veronese FM (2004) Bioorg Med Chem 12:5031
Enzon Inc (1999) US Patent 5 985 263
Applied Research System (1999) Wo Patent 9 955 376
Orsatti L, Veronese FM (1999) J Bioac Comp Polymer 14:429
Harris JM, Guo L, Fang ZH, Morpurgo M (1995) Seventh International Symposium On Recent Advances In Drug Delivery. Salt Lake City, USA
Monfardini C, Schiavon O, Caliceti P, Morpurgo M, Harris JM, Veronese FM (1995) Bioconjug Chem 6:62
Akiyama Y, Otsuka H, Nagasaki Y, Kato M, Kataoka K (2000) Bioconjugate Chem 11:947
Zhang S, Du J, Sun R et al. (2003) Reactive and functional polymer 56:17
Duncan R, Cable HC, Lloyd JB, Rejmanova P, Kopecek J (1984) Makromol Chem 184:1997
Rejmanova P, Pohl J, Baudys M, Kostka V, Kopecek J (1984) Makromol Chem 184:2009
Greenwald RB, Yang K, Zhao H, Conover CD, Lee S, Filpula D (2003) Bioconjug Chem 14:395
Greenwald RB, Choe YH, Conover CD, Shum K, Wu D, Royzen M (2000) J Med Chem 43:475
Choe YH, Conover CD, Wu D et al. (2002) J Control Release 79:55
Schiavon O, Pasut G, Moro S, Orsolini P, Guiotto A, Veronese FM (2004) European J Med Chem 39:123
Caliceti P, Schiavon O, Sartore L, Monfardini C, Veronese FM (1993) J Bioact Biocomp Polym 8:41
Esposito P, Barbero L, Caccia P et al. (2003) Adv Drug Deliv Rev 55:1279
Hooftman G, Herman S, Schacht E (1996) J Bioact Comp Polymer 11:135
Delgado C, Francis GE, Malik F, Fisher D, Parkes V (1997) Pharm Sci 3:59
Monkarsh SP, Ma Y, Aglione A et al. (1997) Anal Biochem 247:434
Veronese FM, Sacca B, Polverido, De Laureto P et al. (2001) Bioconjug Chem 1:62
Wylie DC, Voloch M, Lee S, Liu YH, Cannon-Carlson S, Cutler C, Pramanik B (2001) Pharm Res 18:1354
Uze G, Lutfalla G, Mongensen (1995) J Interferon Cytokine Res 5:3
Tyring SK (1995) Am J Obstet Gynecol 172:1350
Wang YS, Youngster S, Bausch J, Zhang R, Mcnemar C, Wyss DF (2000) Biochemistry 39:10634
Enzon Inc (1999) US Patent 5 985 263
Glue P, Fang JWS, Sabo R et al. (1999) Hepatology 30 (Suppl):A189
Pepinsky RB, Le Page D, Gill JA et al. (2001) J Pharmac Exp Ther 297:1059
Metcalf D (1986) Blood 67:257
Welte K, Gabrilove J, Bronchud MH, Platzer E, Morstyn G (1996) Blood 88:1907
Bowen S, Tare N, Inoue T, Yamasaki M, Okabe M, Horii I, Eliason JF (1999) Exp Hematol 27:425
Eliason JF, Greway A, Tare N et al. (2000) Stem Cells 18:40
Maxygen Holdings Ltd (2002) Wo Patent 0 236 626
Kinstler OB, Brems DN, Lauren SL, Paige AG, Hamburger JB, Treuheit MJ (1995) Pharm Res 13:996
Wong SS (ed) (1991) Reactive groups of proteins and their modifying agents. In: Chemistry of protein conjugation and cross-linking. CRC Press, Boca Raton, p 13
Lok S, Kaushansky K, Holly RD et al. (1994) Nature 369:565
Farese A, Hunt P, Macvitie TJ (1995) Blood 86:54
Kuter DJ, Beeler DLl, Rosemberg RD (1994) Proc Natl Acad Sci 369:11104
De-Boer RH, Roskos LK, Cheung E et al. (2000) Growth Factors 18:215
Guerra PI, Acklin C, Kosky AA, Davis JM, Treuheit MJ, Brems DN (1998) Pharm Res 15:1822
Chawla RK, Parks JS, Rudman D (1983) Annu Rev Med 34:519
Clark R, Olson K, Fuh G, Marian M et al. (1996) J Biol Chem 271:21969
Frohman LA, Jansson JO (1986) Endocr Rev 7:223
Lance VA, Murphy WA, Sueiras-Diaz J, Coy DH (1984) Biochem Biophys Res Commun 119:265
Piquet G, Gatti M, Barbero L, Traversa S, Caccia P, Esposito P (2002) J Chrom A944:141
D'Antonio M, Louveau I, Esposito P, Bartolino M, Canali S (2004) Growth Horm Igf Res 14:226
Ares Trading Sa (2002) Wo Patent 0 228 437
Goffin V, Bernichtein S, Carriere O, Bennett WF, Kopchick JJ, Kelly PA (1999) Endocrinology 140:3853
Parkinson C, Scarlett JA, Trainer PJ (2003) Adv Drug Deliv Rev 55:1303
King DJ (1998) Preparation, structure and function of monoclonal antibodies. In: Application and engineering of monoclonal antibodies. Taylor and Francis, London, p 1
King DJ, Adair JR (1999) Curr Opin Drug Discov Dev 2:110
Walsh G (2000) Nat Biotechnol 18:831
Chapman AP (2002) Adv Drug Deliv Rev 54:531
Koumenis IL, Shahrokh Z, Leong S, Hsei V, Deforge L, Zapata G (2000) Int J Pharm 198:83
Anderson WL, Tomasi TB (1988) J Immunol Methods 109:37
Maeda H, Wu J, Sawa T, Matsumura Y, Hori K (2000) J Control Release 65:271
Takashina K, Kitamura K, Yamaguchi T et al. (1991) J Cancer Res 82:1145
Pedley RB, Boden JA, Boden R, Dale R, Begent RH (1994) Br J Cancer 70:521
Wen X, Wu Qp, Lu Y, Fan Z, Charnsangavej C, Wallace S, Chow D, Li C (2001) Bioconjug Chem 12:545
Old LJ, Welt S (2003) US Patent 2003 031 671
Immunomedics Inc (1997) US Patent 5 670 132
Hinds KD, Kim SW (2002) Adv Drug Deliv Rev 54:505
Holtsberg FW, Ensor CM, Steiner MR, Bomalaski JS, Clark MA (2002) J Control Release 80:259
Amgen Inc (2003) US Patent 6 586 398
Amgen Inc (2002) US Patent 6 420 339
Hoffman La Roche (2000) US Patent 6 025 324
Applied Research System (1999) Wo Patent 9 955 377
Bolder Biotechnology Inc (1999) Wo Patent 9 903 887
Smith KA (1988) Science 240:1169
Goodson RJ, Katre NV (1990) Biotechnology 8:343
Chapman AP, Antoniw P, Spitali M, West S, Stephens S, King DJ (1999) Nat Biotechnol 17:780
Eistein Coll Med (1996) US Patent 5 585 484
Sato H (2002) Adv Drug Deliv Rev 54:487
Gorman JJ, Folk JE (1980) J Biol Chem 255:1175
Mcdonagh RP et al. (1981) Febs Lett 127:174
Sato H, Hayashi E, Yamada N, Yatagai M, Takahara Y (2001) Bioconjugate Chem 12:701
Neose Technologies Inc (2004) US Patent 2004 132 640
Chen T, Small DA, Wu LQ, Rubloff GW et al. (2003) Langmuir 19:9382
Lewinska M, Seitz C, Skerra A, Schmidtchen FP (2004) Bioconjug Chem 15:231
Zalipsky S, Menon-Rudolph Hydrazine S (1998) Derivatives 0f poly(ethylene glycol) and their conjugates. In: Harris JM (ed) Poly(ethylene glycol) chemistry: biotechnical and biomedical applications, 2nd edn. Plenum, New York, p 319
Saxon E, Bertozzi CR (2000) Science 287:2007
Cazalis CS, Haller CA, Sease-Cargo L, Chaikof EL (2004) Bioconjug Chem 15:1005
Murad KL, Mahany KL, Kuypers FA, Brugnara C, Eaton JW, Scott MD (1999) Blood 93:2121
Scott MD, Chen AM (2004) Transfusion clinique et biologique 11:40
Abuchowski A, Mccoy R, Palczuk NC, Van Es T, Davis FF (1977) J Biol Chem 252:3582
Greenwald RB (2001) J Control Release 74:159
Greenwald RB, Conover Cd, Choe Yh (2000) Crit Rev Ther Drug Carr Syst 17:101
Veronese FM, Schiavon O, Pasut G, Mendichi R, Andersson L, Tsirk A, Ford J, Wu G, Kneller S, Davies J, Duncan R (2005) Bioconjug Chem 16:775
Andersson L, Davies J, Duncan R, Ferruti P, Ford J, Kneller S, Mendichi R, Pasut G, Schiavon O, Tsirk A, Veronese FM, Vincenzi V, Wu G (2005) Biomacromol 6:914
Genentech Inc (2000) US Patent 6 057 292
Maeda H, Ueda M, Morinaga T, Matsumoto T (1985) J Med Chem 28:455
Duncan R, Kopeckova-Rejmanova P, Strohalm J, Hume I, Cable HC, Pohl J, Lloyd JB, Kopecek J (1987) Br J Cancer 55:165
Acknowledgments
The authors thank the financial support of MURST 40%.
Author information
Authors and Affiliations
Corresponding author
Editor information
Rights and permissions
About this chapter
Cite this chapter
Pasut, G., Veronese, F.M. PEGylation of Proteins as Tailored Chemistry for Optimized Bioconjugates. In: Satchi-Fainaro, R., Duncan, R. (eds) Polymer Therapeutics I. Advances in Polymer Science, vol 192. Springer, Berlin, Heidelberg. https://doi.org/10.1007/12_022
Download citation
DOI: https://doi.org/10.1007/12_022
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-29210-4
Online ISBN: 978-3-540-32945-9
eBook Packages: Chemistry and Materials ScienceChemistry and Material Science (R0)